Not checkedNot checked for notices yet.
Nasopharyngeal colonization with methicillin-resistant staphylococcus aureus and mortality among patients in an intensive care unit Colonización nasal por el staphylococcus aureus resistente a la meticilina y mortalidad en pacientes de una unidad de terapia intensiva Colonização nasal por staphylococcus aureus resistente à meticilina e mortalidade em pacientes de uma unidade de terapia intensiva
Cristiane Ravagnani Fortaleza, Edson Carvalho de Melo, Carlos Magno Castelo Branco Fortaleza
Revista Latino-Americana de Enfermagem · 2009
doi:10.1590/s0104-11692009000500013 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Nasopharyngeal colonization with Methicillin-resistant Staphylococcus aureus (MRSA) is common in critically ill patients, but its effect on patient prognosis is not fully elucidated. A retrospective cohort study was carried out enrolling 122 patients from an intensive care unit who were screened weekly for nasopharyngeal colonization with MRSA. The outcomes of interest were: general mortality and mortality by infection. Several exposure variables (severity of illness, procedures, intercurrences and MRSA nasopharyngeal colonization) were analyzed through univariate and multivariable models. Factors significantly associated with mortality in general or due to infection were: APACHE II and lung disease. The performance of surgery predicted favorable outcomes. MRSA colonization did not predict mortality in general (OR=1.02; 95%CI=0.35-3.00; p=0.97) or by infectious causes (OR=0.96; 95%CI=0.33-2.89; p=0.96). The results suggest that, in the absence of severity of illness factors, colonization with MRSA is not associated with unfavorable outcomes.
Abstract licence: CC BY
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.